They can, but many won’t. Sold IMMU in January and bought CYDY for .80 The more— thanks to this board- that I’ve learned, the more I kept buying. There is NO OTHER drug that compares. It won’t be easy—IMMU has a high percentage of institutional investors, a lot of cash due to a recent dilution, BUT their drug sucks compared to LERO. Science must prevail in the long run. I have not sold/traded any shares.